Splenic sclerosing haemangioma causes false-positive finding at FDG-PET

• References

• 1 Abbott RM, Levy AD, Aguilera NS. et al. From the archives of the AFIP: primary vascular neoplasms of the spleen: radiologic-pathologic correlation. Radiographics 2004; 24: 1137-1163.
• 2 Cheuk W, Chan J. Mesenchymal tumors and tumorlike lesions of the spleen. In: Fletcher C. (ed) Diagnostic Histopathology of Tumors. 2007; 1304-1309.
• 3 Rabushka LS, Kawashima A, Fishman EK. Imaging of the spleen: CT with supplemental MR examination. Radiographics 1994; 14: 307-332.
• 4 Ramani M, Reinhold C, Semelka RC. Splenic hemangiomas and hamartomas: MR imaging characteristics of 28 lesions. Radiology 1997; 202: 166-172.
• 5 Shintaro N, Minori S, Yuji I. et al. A case of splenic sclerosing hemangioma. J Japan Surg Assoc 2004; 65: 2468-2472.
• 6 Rini JN, Leonidas JC, Tomas MB. et al. ¹⁸F-FDG PET versus CT for evaluating the spleen during initial staging of lymphoma. J Nucl Med 2003; 44: 1072-1074.
• 7 Kobe C, Dietlein M, Mauz-Körholz C. FDG-PET in Hodgkin lymphoma. Nuklearmedizin 2008; 47: 235-238.
• 8 Doyle DJ, Khalili K, Guindi M, Atri M. Imaging features of sclerosed hemangioma. AJR Am J Roentgenol 2007; 189: 67-72.
• 9 Edoute Y, Ben-Haim SA, Ben-Arie Y. et al. Difficult preoperative diagnosis of a patient with sclerosing splenic hemangioma. Am J Gastroenterol 1989; 84: 817-819.
• 10 Metser U, Miller E, Kessler A. Solid splenic masses: evaluation with ¹⁸F-FDG PET/CT. J Nucl Med 2005; 46: 52-59.
• 11 La Fougère C, Pfluger T, Schneider V. Restaging of patients with lymphoma – Comparison of low dose CT (20 mAs) with contrast enhanced diagnostic CT in combined [¹⁸F]-FDG PET/CT. Nuklearmedizin 2008; 47: 37-42.